Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno
Mandate

Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno

June 21, 2021 Employment and Benefits Commercial Agreements M&A IT, Telecommunications and Outsourcing Real Estate and Construction Corporate Crime & Compliance Intellectual Property

Vinge advises Destiny (a portfolio company of Apax Partners) in connection with its acquisition of the Soluno group (“Soluno”).

Soluno is one of the leading unified communications as a service providers in Europe. The acquisition gives Destiny an instantly strong position in Sweden and also leads to globalisation for Soluno. Following the acquisition, Destiny will comprise of more than 600 employees across 6 countries and is expected to generate a turnover of SEK 1.7 billion in 2021.

Vinge’s team mainly consisted of Christina Kokko, Ulrich Ziche, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements and GDPR), Mathilda Persson (IT), Ulf Pyk (Real Estate), Josefine Lanker (Banking and Financing), Ebba Svenburg (Employment), Tove Lövgren Frisk (Compliance), Felizia Wiker (IP) and Sara Dahlroos Sköld (VDR specialist).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026